Up to 80 percent of strokes are preventable through early detection and the aggressive management of cardiovascular risk factors, clinicians told members of the Oireachtas during a recent briefing at Leinster House. The medical experts urged Irish lawmakers to shift the national healthcare strategy away from reactive treatment and toward a systemic, prevention-led model to curb the incidence of preventable strokes in Ireland.
At the center of this effort is the urgent need for national cardiovascular risk-prevention clinics. Clinicians argued that the current Irish health system is characterized by inconsistent detection, fragmented care, and inadequate follow-up, leaving many at-risk patients unaware of their condition until a catastrophic event occurs. By establishing standardized clinics, the health service could move from “pockets of excellence” to a uniform national delivery of care.
The briefing, held ahead of World Hypertension Day on May 17, highlighted hypertension—or high blood pressure—as the primary, modifiable driver of stroke and cardiovascular disease. Because hypertension often presents no obvious symptoms, it is frequently referred to as a “silent killer,” making proactive screening essential for public health.
The Gap Between Risk and Prevention
The scale of the challenge is reflected in the data provided by the Irish Heart Foundation, which notes that approximately 7,500 strokes occur in Ireland annually. Crucially, the foundation estimates that 6,000 of these cases could be avoided through targeted interventions, such as the consistent monitoring of hypertension in high-risk populations.
Dr. Susan Connolly, an integrated care cardiologist at Galway University Hospital, emphasized that while hypertension is one of the most addressable risk factors, the system’s current failure to detect it early undermines patient outcomes. “Unfortunately our current health system features inconsistent detection, fragmented care, and inadequate follow-up,” Dr. Connolly said, adding that the goal is to foster a “prevention-focused, evidence-based, cost-effective pathway” created in partnership with patients.
The lack of a streamlined pathway means that many patients are only identified as having high blood pressure after they have already suffered a cardiovascular event. For a physician, this represents a missed window of opportunity where simple medication and lifestyle adjustments could have preserved a patient’s quality of life and reduced the burden on acute hospital services.
Moving Toward a National Clinical Pathway
To address these systemic gaps, an Expert Steering Group on Hypertension Management has been established. This group is tasked with developing a comprehensive clinical pathway that provides a clear roadmap for both healthcare providers and patients, ensuring that screening and management are not dependent on a patient’s location or the specific clinic they attend.
Prof Rónán Collins, a consultant geriatrician at Tallaght University Hospital, noted that prevention requires a “deliberate decision to detect earlier, act earlier and more consistently.” He advocated for the transition to national cardiovascular risk-prevention clinics that align with the EU Safe Hearts plan, an initiative aimed at improving cardiovascular health outcomes across Europe.
The proposed clinics would serve as hubs for integrated care, focusing on:
- Systematic screening of at-risk populations to identify hypertension early.
- Coordinated management plans to reduce cardiovascular risk factors.
- Consistent follow-up care to ensure blood pressure remains within target ranges.
- Patient education to empower individuals in managing their own cardiovascular health.
Tackling Resistant Hypertension and Patient Involvement
While many patients respond well to standard hypertension treatments, a subset of the population suffers from “resistant hypertension,” where blood pressure remains high despite the use of multiple medications. Addressing this complex condition requires a more nuanced approach to care.
The University of Galway is currently leading the development of a specific resistant hypertension pathway. Unlike traditional clinical guidelines, this project seeks to be informed by the lived experience of patients—specifically how they understand and describe their blood pressure and the challenges they face in managing it. This patient-centered approach is intended to increase treatment adherence and improve clinical outcomes.
As part of a national “call-to-action,” the University of Galway is seeking public involvement to help shape this pathway. Members of the public interested in contributing their perspectives on hypertension management are encouraged to contact the university at [email protected].
| Current System State | Proposed Prevention Model |
|---|---|
| Inconsistent detection of hypertension | National screening and risk-prevention clinics |
| Fragmented, reactive care | Integrated, evidence-based clinical pathways |
| Delayed detection (often post-stroke) | Early detection and proactive management |
| Localized “pockets of excellence” | Uniform national delivery of care |
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a licensed healthcare provider for diagnosis and treatment of hypertension or cardiovascular concerns.
The next phase of this initiative involves the Expert Steering Group finalizing the clinical pathway for hypertension management, which will serve as the blueprint for the rollout of the new prevention clinics. Further updates on the implementation of these clinics are expected as the Department of Health reviews the recommendations provided during the Oireachtas briefing.
Do you have experience managing high blood pressure or navigating the Irish health system? Share your thoughts in the comments or share this article to raise awareness about stroke prevention.
